| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.38B | -3.0% |
| Cost of Revenue | $7.53B | -4.1% |
| R&D Expense | $45.0M | +55.2% |
| SG&A Expense | $1.59B | +10.5% |
| Operating Income | $2.82B | -4.0% |
| Interest Expense | $871.5M | +27.5% |
| Pre-tax Income | $2.40B | +4.6% |
| Income Tax | $585.3M | +5.6% |
| Net Income | $1.81B | +4.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $622.0M | -54.7% |
| Short-term Investments | $282.7M | -83.1% |
| Accounts Receivable | $660.8M | +9.9% |
| Inventory | $307.4M | +5.2% |
| Current Assets | $2.05B | -51.3% |
| Total Assets | $11.24B | -5.2% |
| Current Liabilities | $4.55B | -15.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.57B | -33.3% |
| Capital Expenditures | $122.5M | -21.9% |
| Investing Cash Flow | -$229.1M | +96.7% |
| Financing Cash Flow | -$2.09B | -144.9% |
| Free Cash Flow | $1.44B | -34.1% |
| Long-term Debt |
| $11.76B |
| -11.5% |
| Total Liabilities | $16.95B | -12.7% |
| Stockholders' Equity | -$5.70B | +24.5% |